'Transplant' Renewed for Second Season at NBC

Hamza Haq in Transplant
Yan Turcotte/Sphere Media/CTV/NBC

NBC is sticking with its Canadian import Transplant.

The network has renewed the medical drama for a second season in the United States, with the news coming two days after it concluded its run on NBC. The show's Canadian home, CTV, picked up the series for a second season in June following its conclusion there.

Transplant debuted Sept. 1 on NBC and has put up decent ratings numbers for the network as part of a patchwork fall lineup that didn't see any of the network's regular scripted series debut until late October. Initial airings have averaged about 5.7 million viewers and a 0.7 rating in adults 18-49 with a week of delayed viewing. Adding digital and streaming platforms bumps the show up to 7.7 million viewers per episode (measured from its series debut), and NBC says the series premiere has registered a 1.8 rating in the 18-49 demographic across all platforms.

Those numbers, while well below some of NBC's established dramas, nonetheless make Transplant the No. 2 first-year drama of the season thus far, behind ABC's Big Sky.

Transplant stars Hamza Haq as Dr. Bashir "Bash" Hamed, a Syrian doctor who, along with his sister, Amira (Sirena Gulamgaus), flees the war-torn country and looks to build a new life in Canada, while also restarting his medical career. Laurence Leboeuf, John Hannah, Jim Watson and Ayisha Issa also star.

Sphere Media produces the series in association with CTV and Universal Studio Group's NBCUniversal International Studios. Creator Joseph Kay executive produces with Jocelyn Deschenes, Bruno Dube, Randy Lennox, Virginia Rankin, Jeremy Spry and Tara Woodbury.